Literature DB >> 34236417

Lipoprotein(a) and Cardiovascular Diseases.

Hannah Miksenas1, James L Januzzi1,2, Pradeep Natarajan1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34236417     DOI： 10.1001/jama.2021.3632

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Error in Figure.

Authors: 
Journal:  JAMA       Date:  2022-01-04       Impact factor: 56.272

2.  Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population.

Authors:  Alexandre Vallée
Journal:  Front Cardiovasc Med       Date:  2022-05-27

3.  Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren.

Authors:  Yara Azar; Marie-Hélène Gannagé-Yared; Elie Naous; Carine Ayoub; Yara Abou Khalil; Elise Chahine; Sandy Elbitar; Youmna Ghaleb; Catherine Boileau; Mathilde Varret; Petra El Khoury; Marianne Abifadel
Journal:  Metabolites       Date:  2022-05-31

4.  Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations.

Authors:  Kongyong Cui; Hao-Yu Wang; Dong Yin; Chenggang Zhu; Weihua Song; Hongjian Wang; Lei Jia; Dong Zhang; Chenxi Song; Lei Feng; Kefei Dou
Journal:  Front Cardiovasc Med       Date:  2021-12-20

Review 5.  Lipoprotein(a): Insights for the Practicing Clinician.

Authors:  Pyotr Telyuk; David Austin; Ahai Luvai; Azfar Zaman
Journal:  J Clin Med       Date:  2022-06-25       Impact factor: 4.964
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.